Gropep Bioreagents Overview

  • Founded

  • 1988

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 80

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 2

Gropep Bioreagents General Information

Description

Developer of biologically active proteins designed for culture and biomedical research. The company's biologically active proteins for cell are used in the production of biological therapeutics such as monoclonal antibodies, recombine proteins and vaccines enabling clients to develop bio pharmaceuticals from pre-clinical trials.

Contact Information

Website
www.gropep.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Novozymes
Primary Office
  • PO Box 10065 BC
  • Adelaide, South Australia 5000
  • Australia
+61 (08) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gropep Bioreagents Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gropep Bioreagents‘s full profile, request access.

Request a free trial

Gropep Bioreagents Executive Team (3)

Name Title Board Seat Contact Info
Robert Finder Managing Director & Chief Executive Officer
Anthony Mitchell Chief Financial Officer
Chris Goddard Managing Director
To view Gropep Bioreagents’s complete executive team members history, request access »

Gropep Bioreagents Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial